Sam Pharmaceut Launches WHO-Standard Factory in Nigeria

Sam Pharmaceut has inaugurated a new manufacturing facility in Ota, Ogun State, Nigeria, designed to meet World Health Organization (WHO) Good Manufacturing Practice (GMP) standards. The factory aims to enhance local drug production capacity and reduce reliance on imported medicines.

It is financed by a 3 billion Naira term loan from First City Monument Bank, in partnership with the Bank of Industry, and is expected to produce 400 million tablets, 50 million capsules, two million bottles of syrup, and one million pouches monthly. The project aligns with the Nigerian government's strategy to expand local pharmaceutical production, as stated by the Minister of State for Health, Adekunle Salako.

Ogun State's Deputy Governor, Noimot Salako-Oyedepo, emphasized the factory's role in job creation and improving access to essential medicines. Mojisola Adeyeye, Director General of NAFDAC, noted that the facility reflects Nigeria's growing compliance with global pharmaceutical standards.

Amit Bhojwani, Chairman and CEO of Sam Pharmaceut, expressed confidence in the company's ability to strengthen Nigeria's pharmaceutical brand in the global market.